Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis-Reference-Cited by-同舟云学术

Statin use in patients with elevated serum hepatic transaminases at baseline: A meta-analysis

Published:2021-05 Issue:5 Volume:31 Page:1357-1364
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Masson Walter^ORCID,Lobo Martín,Masson Gerardo,Molinero Graciela,Casciato Paola

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference40 articles.

1. Comparative lipid-lowering/increasing efficacy of 7 statins in patients with dyslipidemia, cardiovascular diseases, or diabetes mellitus: systematic review and network meta-analyses of 50 randomized controlled trials;Zhang;Cardiovasc Ther,2020

2. 2018AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology/American heart association task force on clinical practice guidelines;Grundy;Circulation,2019

3. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Atherosclerosis,2019

4. The myth of statin-induced hepatotoxicity;Bader;Am J Gastroenterol,2010

5. Statins and nonalcoholic fatty liver disease in the era of precision medicine: more friends than foes;Nascimbeni;Atherosclerosis,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin Intolerance: An Overview for Clinicians;Contemporary Diabetes;2023

2. PCSK9 Inhibitor: Safe Alternative to Fill the Treatment Gap in Statin-Limited Conditions?;Reviews in Cardiovascular Medicine;2022-11-09

3. Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers;Journal of Korean Medical Science;2022